欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Azacitidine Mylan	Human	azacitidine	azacitidine	EMEA/H/C/004984	Mylan Pharmaceuticals Limited	2020/03/27	Authorised
Nubeqa	Human	darolutamide	darolutamide	EMEA/H/C/004790	Bayer AG	2020/03/27	Authorised
Nustendi	Human	bempedoic acid;ezetimibe	bempedoic acid;ezetimibe	EMEA/H/C/004959	Daiichi Sankyo Europe GmbH	2020/03/27	Authorised
Staquis	Human	crisaborole	Crisaborole	EMEA/H/C/004863	Pfizer Europe MA EEIG	2020/03/27	Withdrawn
Lyumjev (previously Liumjev)	Human	insulin lispro	insulin lispro	EMEA/H/C/005037	Eli Lilly Nederland B.V.	2020/03/24	Authorised
Azacitidine betapharm	Human	azacitidine	azacitidine	EMEA/H/C/005075	betapharm Arzneimittel GmbH	2020/03/24	Authorised
Givlaari	Human	givosiran	Givosiran	EMEA/H/C/004775	Alnylam Netherlands B.V.	2020/03/02	Authorised
Beovu	Human	brolucizumab	brolucizumab	EMEA/H/C/004913	Novartis Europharm Limited	2020/02/13	Authorised
Recarbrio	Human	imipenem;cilastatin;relebactam	imipenem monohydrate;cilastatin sodium;relebactam monohydrate	EMEA/H/C/004808	Merck Sharp & Dohme B.V.	2020/02/13	Authorised
Amsparity	Human	adalimumab	adalimumab	EMEA/H/C/004879	Pfizer Europe MA EEIG	2020/02/13	Authorised
Azacitidine Accord	Human	azacitidine	azacitidine	EMEA/H/C/005147	Accord Healthcare S.L.U.	2020/02/13	Authorised
Polivy	Human	polatuzumab vedotin	polatuzumab vedotin	EMEA/H/C/004870	Roche Registration GmbH	2020/01/16	Authorised
Sunosi	Human	solriamfetol	solriamfetol hydrochloride	EMEA/H/C/004893	Atnahs Pharma Netherlands B.V.	2020/01/16	Authorised
Mayzent	Human	siponimod	siponimod fumaric acid	EMEA/H/C/004712	Novartis Europharm Limited	2020/01/13	Authorised
Deferasirox Accord	Human	deferasirox	deferasirox	EMEA/H/C/005156	Accord Healthcare S.L.U.	2020/01/09	Authorised
Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan)	Human	clopidogrel;acetylsalicylic acid	acetylsalicylic acid;clopidogrel hydrogen sulfate	EMEA/H/C/004996	Mylan Pharmaceuticals Limited	2020/01/09	Authorised
Isturisa	Human	osilodrostat	osilodrostat phosphate	EMEA/H/C/004821	Recordati Rare Diseases	2020/01/09	Authorised
Tavlesse	Human	fostamatinib	Fostamatinib disodium	EMEA/H/C/005012	Instituto Grifols S.A.	2020/01/09	Authorised
Cegfila (previously Pegfilgrastim Mundipharma)	Human	pegfilgrastim	pegfilgrastim	EMEA/H/C/005312	Mundipharma Corporation (Ireland) Limited	2019/12/19	Authorised
Spravato	Human	esketamine	esketamine hydrochloride	EMEA/H/C/004535	Janssen-Cilag International NV	2019/12/18	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-